# FDA 483 - Viyash Life Sciences Private Limited - April 25, 2025

Source: https://www.globalkeysolutions.net/records/483/viyash-life-sciences-private-limited/8542a8db-79bd-4f89-928b-23e99d99d6a3

> FDA 483 for Viyash Life Sciences Private Limited on April 25, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Viyash Life Sciences Private Limited
- Inspection Date: 2025-04-25
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: An FDA inspection of Viyash Life Sciences Private Limited, an API manufacturer in Taluka Panval, Maharashtra, India, revealed two significant observations. The firm failed to perform required testing for raw materials used in active pharmaceutical ingredients and also had an inadequate stability testing program, specifically lacking appearance/description testing for an API.

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)

Company: https://www.globalkeysolutions.net/companies/viyash-life-sciences-private-limited/3859ae2f-3b52-4707-919f-3643bbc33810

Office: https://www.globalkeysolutions.net/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8